Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient.
Hughes CM, Gregory GP, Pierce AB, Druce JD, Catton M, Chong B, Sherry NL, Graham M, Chen M, Salvaris R, Eise N, Lee JYH, McQuilten Z, Crouch S, Looker C, Korman TM, Stuart RL.
Hughes CM, et al. Among authors: korman tm.
Infect Control Hosp Epidemiol. 2022 Jun;43(6):820-822. doi: 10.1017/ice.2021.120. Epub 2021 Mar 19.
Infect Control Hosp Epidemiol. 2022.
PMID: 33736721
Free PMC article.
No abstract available.